Literature DB >> 3295782

Expression of porcine pancreatic phospholipase A2. Generation of active enzyme by sequence-specific cleavage of a hybrid protein from Escherichia coli.

P de Geus, C J van den Bergh, O Kuipers, H M Verheij, W P Hoekstra, G H de Haas.   

Abstract

The cDNA coding for the porcine pancreatic prophospholipase A2 (proPLA) has been cloned and expressed in E. coli. Expression of proPLA could only be obtained in the form of intracellular aggregates after fusing the 15 kDa proPLA to a large (greater than or equal to 45 kDa) bacterial peptide. The fusion protein was readily purified from cell lysates, and specifically cleaved. Cleavage of the fusion protein was achieved with either hydroxylamine (at Asn/Gly sequences in the denatured protein), or trypsin (between the pro- and the mature PLA in the renatured fusion protein). The former method releases a proPLA-like enzyme, while the latter directly yields PLA. Renaturation of the fusion protein was made possible by the use of a recently reported new S-sulphonation method. The released (pro)PLA was purified (yields of 2-3 mg/ltr of culture medium), and showed identical properties compared to native (pro)PLA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3295782      PMCID: PMC340779          DOI: 10.1093/nar/15.9.3743

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

Review 1.  Protein engineering.

Authors:  R J Leatherbarrow; A R Fersht
Journal:  Protein Eng       Date:  1986 Oct-Nov

2.  The amino acid sequence of the phospholipase A2 isoenzyme from porcine pancreas.

Authors:  W C Puijk; H M Verheij; P Wietzes; G H de Haas
Journal:  Biochim Biophys Acta       Date:  1979-10-24

3.  Immunological studies on pancreatic phospholipase A2. Antigenic characterization of the NH2-terminal region.

Authors:  H Meijer; M J Meddens; R Dijkman; A J Slotboom; G H de Haas
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

4.  A simple and very efficient method for generating cDNA libraries.

Authors:  U Gubler; B J Hoffman
Journal:  Gene       Date:  1983-11       Impact factor: 3.688

5.  Rapid and quantitative recovery of DNA fragments from gels by displacement electrophoresis (isotachophoresis).

Authors:  L G Ofverstedt; K Hammarström; N Balgobin; S Hjertén; U Pettersson; J Chattopadhyaya
Journal:  Biochim Biophys Acta       Date:  1984-06-16

6.  Pancreatic phospholipase A2: isolation of the human gene and cDNAs from porcine pancreas and human lung.

Authors:  J J Seilhamer; T L Randall; M Yamanaka; L K Johnson
Journal:  DNA       Date:  1986-12

7.  Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

Authors:  H Aviv; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

8.  Dog and rat pancreatic phospholipases A2: complete amino acid sequences deduced from complementary DNAs.

Authors:  O Ohara; M Tamaki; E Nakamura; Y Tsuruta; Y Fujii; M Shin; H Teraoka; M Okamoto
Journal:  J Biochem       Date:  1986-03       Impact factor: 3.387

9.  The use of synthetic oligonucleotides as hybridization probes. II. Hybridization of oligonucleotides of mixed sequence to rabbit beta-globin DNA.

Authors:  R B Wallace; M J Johnson; T Hirose; T Miyake; E H Kawashima; K Itakura
Journal:  Nucleic Acids Res       Date:  1981-02-25       Impact factor: 16.971

10.  Construction of a new family of high efficiency bacterial expression vectors: identification of cDNA clones coding for human liver proteins.

Authors:  K K Stanley; J P Luzio
Journal:  EMBO J       Date:  1984-06       Impact factor: 11.598

View more
  2 in total

1.  Identification of multiple isoforms of the low-affinity human IgG Fc receptor.

Authors:  T Seki
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  Interfacial catalysis: the mechanism of phospholipase A2.

Authors:  D L Scott; S P White; Z Otwinowski; W Yuan; M H Gelb; P B Sigler
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.